AtriCure, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings
AtriCure, Inc. (ATRC) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings of -$57.00 thousand for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-07-31.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 · last filed 2015-07-31
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2015-06-30 was -$43.00K, a 326.32% decline year-over-year.
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2015-03-31 was -$14.00K, a 113.33% decline year-over-year.
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2014-12-31 was -$92.00K.
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2014-09-30 was $151.00K.
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2013 was -$272.00K, a 251.96% decline from fiscal 2012.
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2012 was $179.00K, a 678.26% increase from fiscal 2011.
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2011 was $23.00K, a 86.06% decline from fiscal 2010.
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2010 was $165.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 12 month as first filed |
|---|---|---|---|---|---|
| 2015-06-30 | -$43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | -$57.00K 10-Q · filed 2015-07-31 | -$149.00K derived: sum of 3 quarters · filed 2015-07-31 | $2.00K derived: sum of 4 quarters · filed 2015-07-31 | |
| 2015-03-31 | -$14.00K 10-Q · filed 2015-05-01 | -$106.00K derived: sum of 2 quarters · filed 2015-07-31 | $45.00K derived: sum of 3 quarters · filed 2015-07-31 | $64.00K derived: sum of 4 quarters · filed 2015-07-31 | |
| 2014-12-31 | -$92.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2015-07-31 | $59.00K derived: sum of 2 quarters · filed 2015-07-31 | $78.00K derived: sum of 3 quarters · filed 2015-07-31 | $183.00K 10-Q · filed 2015-07-31 | |
| 2014-09-30 | $151.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $170.00K derived: sum of 2 quarters · filed 2014-10-31 | $275.00K 10-Q · filed 2014-10-31 | $71.00K derived: sum of 4 quarters · filed 2015-03-02 | |
| 2014-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-30 | $124.00K 10-Q · filed 2014-07-30 | -$80.00K derived: sum of 3 quarters · filed 2015-03-02 | -$106.00K derived: sum of 4 quarters · filed 2015-03-02 | |
| 2014-03-31 | $105.00K 10-Q · filed 2014-04-30 | -$99.00K derived: sum of 2 quarters · filed 2015-03-02 | -$125.00K derived: sum of 3 quarters · filed 2015-03-02 | -$181.00K derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-12-31 | -$204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$230.00K derived: sum of 2 quarters · filed 2015-03-02 | -$286.00K derived: sum of 3 quarters · filed 2015-03-02 | -$272.00K 10-K · filed 2015-03-02 | |
| 2013-09-30 | -$26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | -$82.00K derived: sum of 2 quarters · filed 2013-11-01 | -$68.00K 10-Q · filed 2013-11-01 | $270.00K derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-06-30 | -$56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | -$42.00K 10-Q · filed 2013-08-02 | $296.00K derived: sum of 3 quarters · filed 2015-03-02 | $211.00K derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-03-31 | $14.00K 10-Q · filed 2013-05-03 | $352.00K derived: sum of 2 quarters · filed 2015-03-02 | $267.00K derived: sum of 3 quarters · filed 2015-03-02 | ||
| 2012-12-31 | $338.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $253.00K derived: sum of 2 quarters · filed 2015-03-02 | $179.00K 10-K · filed 2015-03-02 | -$179.00K 10-K · filed 2013-03-08 | |
| 2012-09-30 | -$85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | -$159.00K 10-Q · filed 2012-11-02 | |||
| 2012-06-30 | -$74.00K 10-Q · filed 2012-08-03 | ||||
| 2011-12-31 | $23.00K 10-K · filed 2014-03-11 | -$23.00K 10-Q · filed 2012-08-03 | |||
| 2010-12-31 | $165.00K 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |